Left ventricular hypertrophy (LVH) is a consequence of persistent prolonged systemic hypertension. It is initially a compensatory mechanism, but later, left ventricular hypertrophy carries the risk of arrhythmia, congestive heart failure, angina, systolic and diastolic dysfunction, increased severity and risk of myocardial infarction and heart ruptures. The Framingham Heart Study and other studies have shown that LVH is an independent risk factor for cardiovascular morbidity and mortality. Some classes of drugs regress LVH, e.g., ACE inhibitor, AT1 receptor blockers, calcium channel blockers, B blockers, and methyldopa. The effect of diuretics on regression is inconclusive. Aim: To determine the role of indapamide on hypertensive left ven...
Two large trials were conducted to evaluate the effects of an angiotensinconverting-enzyme inhibitor...
Background: Patients (pts) with arterial hypertension (Ht) and left ventricular hypertrophy (LVH) ar...
The PICXEL study is designed to evaluate the effects of long-term administration of very low-dose co...
Left ventricular hypertrophy (LVH) is both a target organ response to chronic arterial hypertension ...
Hypertensive heart disease (HHD) is characterized by left ventricular hypertrophy (LVH), alterations...
BACKGROUND: Increase in left ventricular mass (LVM) may be linked to morbidity and mortality in hype...
Hypertensive left ventricular hypertrophy (LVH) may be detected in about one third of people with hy...
Background: The development and risk potential of hypertension-induced left ventricular (LV) hypertr...
Left ventricular hypertrophy (LVH) is a strong, blood pressure independent cardiovascular risk facto...
The management of left ventricular hypertrophy (LVH) presupposes that the patient is identified by e...
OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (L...
Background: Increase in left ventricular mass (LVM) may be linked to morbidity and mortality in hype...
Left ventricular hypertrophy is a common feature of essential hypertension, and represents at the sa...
It has been well recognized that the presence of left ventricular hypertrophy (LVH) is an adverse fe...
Two large trials were conducted to evaluate the effects of an angiotensinconverting-enzyme inhibitor...
Background: Patients (pts) with arterial hypertension (Ht) and left ventricular hypertrophy (LVH) ar...
The PICXEL study is designed to evaluate the effects of long-term administration of very low-dose co...
Left ventricular hypertrophy (LVH) is both a target organ response to chronic arterial hypertension ...
Hypertensive heart disease (HHD) is characterized by left ventricular hypertrophy (LVH), alterations...
BACKGROUND: Increase in left ventricular mass (LVM) may be linked to morbidity and mortality in hype...
Hypertensive left ventricular hypertrophy (LVH) may be detected in about one third of people with hy...
Background: The development and risk potential of hypertension-induced left ventricular (LV) hypertr...
Left ventricular hypertrophy (LVH) is a strong, blood pressure independent cardiovascular risk facto...
The management of left ventricular hypertrophy (LVH) presupposes that the patient is identified by e...
OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (L...
Background: Increase in left ventricular mass (LVM) may be linked to morbidity and mortality in hype...
Left ventricular hypertrophy is a common feature of essential hypertension, and represents at the sa...
It has been well recognized that the presence of left ventricular hypertrophy (LVH) is an adverse fe...
Two large trials were conducted to evaluate the effects of an angiotensinconverting-enzyme inhibitor...
Background: Patients (pts) with arterial hypertension (Ht) and left ventricular hypertrophy (LVH) ar...
The PICXEL study is designed to evaluate the effects of long-term administration of very low-dose co...